| Literature DB >> 25395914 |
Samira M Mahboub1, May N Al-Muammar2, Azza A Elareefy3.
Abstract
Most of the previous studies on osteoporosis have focused on post-menopausal women, and more research is needed to evaluate its prevalence in pre-menopausal women. This study was carried out to evaluate the prevalence and correlated factors for decreased bone mass density among pre- and post-menopausal women. This was a cross-sectional study carried out in Applied Medical Sciences College under King Saud University. All pre- and post-menopausal women working there were invited to participate in the study. Measurement of bone mass density was done by quantitative ultrasound densitometry. One-fourth of the pre-menopausal females had osteopaenia. There was a significant correlation between having osteoporosis and increasing age, fertility period, parity, menopausal duration, gynaecological age, and presence of co-morbidity, especially hypertension and diabetes mellitus. Pre-menopausal females had high prevalence of osteopaenia (24.8%), and it is recommended to implement health education campaigns demonstrating the preventive measures of osteoporosis.Entities:
Keywords: Calcium; Fertility; Gynaecological age; Osteoporosis; Parity; Pre-menopausal; Saudi Arabia; Soft drink
Mesh:
Year: 2014 PMID: 25395914 PMCID: PMC4221457
Source DB: PubMed Journal: J Health Popul Nutr ISSN: 1606-0997 Impact factor: 2.000
Figure.Diagnostic criteria for osteoporosis proposed by World Health Organization (11)
Distribution of osteopaenia and osteoporosis among pre- and post-menopausal women according to fertility and co-morbidity
| Variable | Group | p value | |||||
|---|---|---|---|---|---|---|---|
| Normal | Osteopaenia | Osteoporosis | |||||
| Pre-menopause | Post-menopause | Pre-menopause | Post-menopause | Pre-menopause | Post-menopause | ||
| Fertility period | 18.5±10.1 | 35.7±4.6 | 17±7.9 | 37.4±5.3 | 28.7±20 | 37±1.2 | p<0.01 |
| Mean±SD | 21.2±11.3 | 25.6±12.2 | 33.4±12.4 | ||||
| Number of co-morbidity | 1.5±0.6 | 2.1±0.9 | 1.4±0.6 | 2.1±0.8 | 2±1 | 2.8±0.4 | p<0.05 |
| Mean±SD | 0.5±0.8 | 0.6±0.9 | 1.5±0.9 | ||||
| Parity | 2.1±2.3 | 6.6±3.2 | 2.6±2.5 | 4.9±2.7 | 6±4.5 | 6.8±1.8 | p<0.01 |
| Mean±SD | 2.8±3 | 3.5±2.8 | 6.4±3 | ||||
| Total | 83 (85.6%) | 14 (14.4%) | 29 (63%) | 17 (37%) | 5 (50%) | 5 (50%) | p<0.01 |
| 97 (63.4%) | 46 (30.1%) | 10 (6.5%) | |||||
SD=Standard deviation;
*Statistically significant;
**Highly significant
Distribution of osteopaenia and osteoporosis among the study sample according to the presence of hypertension and diabetes mellitus
| Variable | Group | p value | ||
|---|---|---|---|---|
| Normal | Osteopaenia | Osteoporosis | ||
| Hypertension | ||||
| No | 87 (68%) | 36 (28.1%) | 5 (3.9%) | p<0.01 |
| Yes | 10 (40%) | 10 (40%) | 5 (20%) | |
| Diabetes mellitus | ||||
| No | 79 (64.2%) | 39 (31.7%) | 5 (4.1%) | p<0.05 |
| Yes | 10 (40%) | 10 (40%) | 5 (20%) | |
*Statistically significant;
**Highly significant
Pearson's bivariate correlation between BMD and investigated risk factors
| Variable | Pearson's correlation | Bone mass T-score |
|---|---|---|
| Age | Pearson's correlation | -0.318 |
| Significant (2-tailed) | 0.000 | |
| Hypertension | Pearson's correlation | -0.211 |
| Significant (2-tailed) | 0.009 | |
| Parity | Pearson's correlation | -0.196 |
| Significant (2-tailed) | 0.021 | |
| Gynaecological age | Pearson's correlation | -0.335 |
| Significant (2-tailed) | 0.000 | |
| Co-morbidity | Pearson's correlation | -0.173 |
| Significant (2-tailed) | 0.034 | |
| Fertility period | Pearson's correlation | -0.278 |
| Significant (2-tailed) | 0.001 | |
| Duration of menopause | Pearson's correlation | -0.351 |
| Significant (2-tailed) | 0.036 |
*Correlation is significant at 0.05 level (2-tailed);
**Correlation is significant at 0.01 level (2-tailed)
Linear regression analysis of variable predicting T-score of BMD
| Model | Unstandardized coefficients | Standardized coefficients | T-score | p | VIF | ||
|---|---|---|---|---|---|---|---|
| B | SE | β | |||||
| Constant | -0.19 | 0.17 | -1.1 | ||||
| Parity | -8.7 | 0.04 | -0.19 | -2.3 | <0.05 | 1.4 | |
SE=Standard error; T=Corresponding t value; VIF=Variance inflation factor
Correlation between calcium intake and BMD
| Variable | Group | p value | ||
|---|---|---|---|---|
| Normal | Osteopaenia | Osteoporosis | ||
| Calcium intake | ||||
| Deficient calcium intake (<1,000 mg/day) | 51 (60%) | 28 (32.9%) | 6 (7.1%) | p>0.05 |
| Average intake (≥1,000 mg/day) | 6 (75%) | 2 (25%) | 0 (0%) | |
| Mean±SD of calcium intake (mg/day) | 567.3±331.3 | 564.9±355.7 | 425.8±306.7 | p>0.05 |
SD=Standard deviation